Doctors Note Logo

Published on: 6/15/2026

Scleroderma: What Causes Skin Tightening, Why It Affects Internal Organs, and How Rheumatologists Monitor

Scleroderma is an autoimmune disease that causes skin tightening when blood vessel injury triggers fibroblasts to overproduce collagen, resulting in fibrosis of the skin and connective tissues. This same fibrotic process can scar the lungs, heart, kidneys, and digestive tract. Rheumatologists monitor patients through skin scores, antibody testing, pulmonary function tests, imaging, and a multidisciplinary care team to detect internal organ involvement early.

Because scleroderma symptoms often overlap with other autoimmune and connective tissue conditions, identifying the cause of your symptoms early is critical to protecting long-term organ health. The sooner you understand what may be driving changes in your skin, circulation, or digestion, the sooner you can pursue targeted testing and treatment. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.

Reviewed for medical accuracy: 06/15/2026

answer background

Explanation

Scleroderma: What Causes Skin Tightening, Why It Affects Internal Organs, and How Rheumatologists Monitor

Scleroderma is an autoimmune disease characterized by hardening and tightening of the skin and connective tissues. This process can also damage blood vessels and internal organs. Understanding the "why" and "how" behind scleroderma symptoms helps patients and clinicians work together to manage the condition effectively.

What Causes Skin Tightening in Scleroderma?

Skin tightening, or fibrosis, is the hallmark of scleroderma. It happens when the body makes too much collagen—a protein that normally provides strength and elasticity. In scleroderma:

  • Immune system activation
    Autoantibodies and inflammatory cells mistakenly target the lining of blood vessels.
  • Vessel injury and reduced blood flow
    Chronic damage to tiny blood vessels (microvasculature) leads to low oxygen delivery to the skin.
  • Fibroblast overdrive
    Fibroblasts (cells that build collagen) become overactive, depositing excessive collagen in the skin's dermal layer.
  • Loss of normal tissue structure
    Healthy skin layers are replaced by dense, stiff collagen, causing the skin to tighten and thicken.

Key Features of Skin Involvement

  • Shiny, smooth appearance
  • Loss of skin lines and flexibility
  • Tightness around the fingers (sclerodactyly)
  • Possible ulcerations at finger tips or joints

Clinically, doctors use the modified Rodnan skin score to grade how much skin is affected, palpating 17 areas of the body on a scale of 0 (normal) to 3 (severe thickening).

Why Scleroderma Impacts Internal Organs

The same process that tightens the skin—blood vessel injury and collagen overproduction—can occur in organs. Over time, fibrosis replaces normal tissue, leading to malfunction.

  1. Lungs

    • Pulmonary fibrosis (scarring of lung tissue) decreases lung capacity.
    • Pulmonary arterial hypertension (PAH) arises when small pulmonary vessels thicken, raising pressure in the lungs.
  2. Heart

    • Fibrosis in the heart muscle can cause arrhythmias or reduce pumping efficiency.
    • Pericardial involvement may lead to fluid accumulation around the heart.
  3. Kidneys

    • Scleroderma renal crisis (SRC) is rare but serious: sudden rise in blood pressure and rapid kidney failure.
    • Early detection and treatment with ACE inhibitors can be life-saving.
  4. Gastrointestinal Tract

    • Esophageal dysmotility: weakened muscle function causes acid reflux, swallowing problems.
    • Intestinal involvement can lead to bloating, malabsorption, diarrhea or constipation.
  5. Blood Vessels

    • Raynaud's phenomenon: exaggerated cold response causes finger/toe color changes (white → blue → red).
    • Digital ulcers develop from poor blood flow.

Common Internal Symptoms

  • Shortness of breath or dry cough
  • Chest pain or palpitations
  • High blood pressure (especially sudden)
  • Heartburn or difficulty swallowing
  • Bloating, diarrhea, malnutrition

How Rheumatologists Monitor Scleroderma

Monitoring is crucial for detecting organ involvement early and guiding treatment. A rheumatologist typically coordinates care, ordering tests at regular intervals or as new symptoms emerge.

1. Clinical Examination

  • Skin assessment using the modified Rodnan skin score
  • Joint and muscle exam for stiffness or weakness
  • Vascular checks for Raynaud's severity and digital ulcers

2. Blood Tests

  • Autoantibodies
    • ANA (antinuclear antibodies) often positive
    • Specific markers: anti–Scl-70 (topoisomerase I), anti–RNA polymerase III
  • Inflammatory markers (ESR, CRP) to gauge active inflammation
  • Kidney function (creatinine, electrolytes) for early renal crisis detection
  • Liver enzymes if medication side effects or overlap syndromes are suspected

3. Pulmonary Evaluation

  • Pulmonary function tests (PFTs)
    • Forced vital capacity (FVC) to measure lung volume
    • DLCO (diffusing capacity) to assess gas exchange
  • High-resolution CT scan of the chest for detailed imaging of lung fibrosis
  • Echocardiogram to estimate pulmonary artery pressures and check heart function

4. Cardiac Studies

  • ECG (electrocardiogram) for arrhythmias
  • Echocardiogram to evaluate heart structure and function
  • Cardiac MRI if myocarditis or fibrosis is suspected

5. Renal Monitoring

  • Blood pressure checks at every visit
  • Urinalysis for protein or blood, indicating kidney involvement
  • Serum creatinine to monitor kidney function

6. Gastrointestinal Assessment

  • Esophageal manometry to test swallowing muscle strength
  • Endoscopy if reflux or ulcers are severe
  • Breath tests to detect bacterial overgrowth in the small intestine

7. Multidisciplinary Care

  • Collaboration with pulmonologists, cardiologists, nephrologists, gastroenterologists, dermatologists, and physical/occupational therapists.
  • Regular vaccination updates (e.g., flu, pneumonia) to reduce infection risk.

Managing Scleroderma Symptoms

While there's no cure, treatments can slow progression, relieve symptoms, and improve quality of life.

  • Immunosuppressants (e.g., methotrexate, mycophenolate) to reduce inflammation and fibrosis.
  • Vasodilators (e.g., calcium channel blockers, PDE-5 inhibitors) to ease Raynaud's and PAH.
  • Proton pump inhibitors for acid reflux and esophageal protection.
  • ACE inhibitors as first-line therapy in scleroderma renal crisis.
  • Physical therapy to maintain joint mobility and prevent contractures.
  • Skin care: moisturizers and wound care for digital ulcers.

Lifestyle measures include smoking cessation (to improve circulation), gentle exercise, and a balanced diet.

When to Seek Medical Advice

If you experience new or worsening scleroderma symptoms—especially:

  • Sudden shortness of breath
  • Rapidly rising blood pressure
  • Chest pain or irregular heartbeat
  • Severe swallowing difficulty

…it's important to contact your doctor promptly. If you're noticing early warning signs like skin tightening, Raynaud's phenomenon, or unexplained fatigue, you can use Ubie's free AI-powered Scleroderma symptom checker to help identify your symptoms and prepare questions before your appointment.

Conclusion

Scleroderma causes skin tightening through immune-mediated vessel injury and collagen overproduction. The same process can affect lungs, heart, kidneys, and the GI tract, making comprehensive monitoring essential. Rheumatologists use clinical exams, lab tests, imaging, and multidisciplinary teams to detect organ involvement early and guide treatment.

Always speak to a doctor about any serious or life-threatening concerns. Early intervention can make a significant difference in outcomes and quality of life.

(References)

  • * Denton, C. P., & Khanna, D. (2023). Pathogenesis and classification of systemic sclerosis. *Lancet Rheumatology*, *5*(9), e506-e517.

  • * Kowal-Bielecka, O., Frantz, C., Allanore, Y., Distler, O., & EULAR Scleroderma Trial and Research (EUSTAR) group. (2023). EULAR recommendations for the management of systemic sclerosis: 2023 update. *Annals of the Rheumatic Diseases*, *82*(11), 1431-1442.

  • * Allanore, Y., & Distler, O. (2020). Monitoring and treatment of systemic sclerosis: a critical appraisal of current guidelines. *Nature Reviews Rheumatology*, *16*(10), 551-561.

  • * Gabrielli, A., Santucci, M., Di Sante, M., Campanati, C., & Cimini, M. (2019). Systemic sclerosis: clinical features and pathogenesis. *F1000Research*, *8*, F1000 Faculty Rev-1658.

  • * Denton, C. P., & Spiera, R. F. (2017). Scleroderma: From Pathogenesis to Therapeutic Strategies. *Annals of Internal Medicine*, *167*(11), 775-786.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.